A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...

Regeneron’s lead counsel was Jonathan D. Polkes of White & Case LLP.

including statins and PCSK9 inhibitors like Amgen's own Repatha (evolocumab) – and that the majority of those cases are Lp(a) driven. Diet and exercise – as well as current dugs – seem to ...

Nine justices in the US Supreme Court voted unanimously to uphold lower district and federal court rulings that invalidated the patents awarded to Amgen for Repatha (evolocumab), which the company ...